Actively Recruiting
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Led by Baylor Research Institute · Updated on 2026-01-30
100
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying advanced lung diseases, including lung transplantation care, to better understand the effects of viral and other infectious exposures on lung transplant and chronic lung disease patients. The study supports biomarker research to identify specific indicators in blood or tissue that can help in early diagnosis and personalized treatment for conditions like interstitial lung disease, chronic obstructive lung disease (COPD), and post-lung transplant rejection. Participants are observed through a biobank registry focused on lung transplant recipients. Clinical data and blood samples are collected during visits to support research on genetic risk, infectious disease susceptibility, and structural lung disease. This observational study gathers human biological specimens to advance understanding, diagnosis, and treatment of chronic lung diseases and improve post-lung transplant care. During the study, participants provide blood samples and clinical data at regular visits. Researchers track patient diagnoses and survival over five years to assess outcomes related to lung transplantation. The collected information helps evaluate biomarkers and genetic factors linked to disease progression and therapy response. Participants are monitored for long-term outcomes, contributing to ongoing research in lung health and transplant success.
CONDITIONS
Brief Title
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years of age or older
- Have undergone lung transplantation at Baylor University Medical Center within the past 10 years
- Be able to understand and sign the informed consent form
You will not qualify if you...
- Have significant documented anemia with hemoglobin less than 8 g/dL
- Have had blood transfusions within the past 3 weeks
- Have active cancer (excluding skin cancers)
- Enrollment is against doctor recommendation
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants are observed through periodic blood sample collections to support research on lung transplant outcomes.
Periodic blood sample collection visits
Trial Site Locations
Total: 1 location
1
Baylor Scott & White Research Institute
Dallas, Texas, United States, 75246
Actively Recruiting
Research Team
S
Susan Mathai, MD
T
Tammy Fischer
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here